Rilpivirine

Back to search

Molecule Structure

Scientific Name

Rilpivirine

Description of the Drug

Rilpivirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used in combination with other antiretrovirals to specifically treat human immunodeficiency virus type 1 (HIV-1).

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB08864

Brand Name(s)

Edurant

Company Owner(s)

Janssen Products Lp, Viiv Healthcare Co, Gilead Sciences Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Human immunodeficiency virus type 1 reverse transcriptase SINGLE PROTEIN INHIBITOR CHEMBL247

Unichem Links

SureChEMBL SCHEMBL385113
Human Metabolome Database HMDB0061725
DrugBank DB08864
PubChem: Thomson Pharma 14926256
PubChem 6451164
LINCS LSM-45777
Nikkaji J2.980.206H J2.576.528A
PDBe T27
BindingDB 222178
EPA CompTox Dashboard DTXSID10198189
DrugCentral 4174
Brenda 61803 146979 165598
ChemicalBook CB81454833
rxnorm EDURANT RILPIVIRINE RILPIVIRINE HYDROCHLORIDE
ChEBI 68606
ZINC ZINC000001554274